International Journal of Molecular Sciences (Apr 2019)

Dysregulation of Circular RNAs in Myotonic Dystrophy Type 1

  • Christine Voellenkle,
  • Alessandra Perfetti,
  • Matteo Carrara,
  • Paola Fuschi,
  • Laura Valentina Renna,
  • Marialucia Longo,
  • Simona Baghai Sain,
  • Rosanna Cardani,
  • Rea Valaperta,
  • Gabriella Silvestri,
  • Ivano Legnini,
  • Irene Bozzoni,
  • Denis Furling,
  • Carlo Gaetano,
  • Germana Falcone,
  • Giovanni Meola,
  • Fabio Martelli

DOI
https://doi.org/10.3390/ijms20081938
Journal volume & issue
Vol. 20, no. 8
p. 1938

Abstract

Read online

Circular RNAs (circRNAs) constitute a recently re-discovered class of non-coding RNAs functioning as sponges for miRNAs and proteins, affecting RNA splicing and regulating transcription. CircRNAs are generated by “back-splicing„, which is the linking covalently of 3′- and 5′-ends of exons. Thus, circRNA levels might be deregulated in conditions associated with altered RNA-splicing. Significantly, growing evidence indicates their role in human diseases. Specifically, myotonic dystrophy type 1 (DM1) is a multisystemic disorder caused by expanded CTG repeats in the DMPK gene which results in abnormal mRNA-splicing. In this investigation, circRNAs expressed in DM1 skeletal muscles were identified by analyzing RNA-sequencing data-sets followed by qPCR validation. In muscle biopsies, out of nine tested, four transcripts showed an increased circular fraction: CDYL, HIPK3, RTN4_03, and ZNF609. Their circular fraction values correlated with skeletal muscle strength and with splicing biomarkers of disease severity, and displayed higher values in more severely affected patients. Moreover, Receiver-Operating-Characteristics curves of these four circRNAs discriminated DM1 patients from controls. The identified circRNAs were also detectable in peripheral-blood-mononuclear-cells (PBMCs) and the plasma of DM1 patients, but they were not regulated significantly. Finally, increased circular fractions of RTN4_03 and ZNF609 were also observed in differentiated myogenic cell lines derived from DM1 patients. In conclusion, this pilot study identified circRNA dysregulation in DM1 patients.

Keywords